What is the main purpose of this 10-Q/A filing?

The main purpose of this filing (Amendment No. 1 to Form 10-Q) is to correct a typographical error on the cover page of the original Form 10-Q. Specifically, it corrects the number of outstanding shares of common stock as of April 30, 2007.

What was the incorrect information and what is the corrected information?

The original filing incorrectly stated the number of outstanding shares as 416,916,711. This amendment corrects that to 466,916,711 shares outstanding as of April 30, 2007.

Does this amendment contain any new financial results or operational updates?

No, this amendment is solely for the correction of a specific data point (number of shares outstanding) and the inclusion of required certifications. It does not alter or add to any other financial or operational information previously reported in the original Form 10-Q for the quarter ended March 31, 2007.

Are there any significant business developments reported in this amendment?

No, this specific filing is a procedural amendment to correct an error. It does not contain any new business developments, strategic changes, or updated financial performance metrics beyond the correction of the share count and the inclusion of certifications.

GILD 10-Q Quarterly Report Q1 FY2007 — Revenue, Net Income, EPS

Summary

Gilead Sciences, Inc. filed an amendment to its Quarterly Report on Form 10-Q for the period ended March 31, 2007. This amendment primarily corrects a typographical error on the cover page regarding the number of outstanding shares, updating it to 466,916,711 as of April 30, 2007. The filing also includes necessary CEO and CFO certifications. Investors should note that this amendment does not alter any other substantive financial or operational information previously reported for the quarter.

Key Highlights

1Amendment filed to correct a typographical error in the number of outstanding shares.
2The number of outstanding shares of common stock as of April 30, 2007, is now accurately reported as 466,916,711.
3The amendment does not change any other financial or operational data from the original Form 10-Q filing.
4Includes CEO and CFO certifications required by SEC rules.
5Gilead Sciences is classified as a large accelerated filer.
6The company is not a shell company.
7The filing confirms that Gilead has met its filing obligations for the preceding 12 months and the last 90 days.

GILEAD SCIENCES, INC. Quarterly Report (Amendment) for Q1 Ended Mar 31, 2007

Summary

Key Highlights

Frequently Asked Questions